School of Medicine
Showing 1-10 of 496 Results
Saul A. Rosenberg, MD, Professor of Lymphoma
Current Research and Scholarly Interests Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.
The research program is highly collaborative with radiation oncology, industry, pathology and dermatology.
Sumbul Ahmad Desai
Clinical Assistant Professor, Medicine - General Medical Disciplines
Current Research and Scholarly Interests Intersection of Media and Medicine, Cost Effective Healthcare, The effect of media on the geriatric population
Clinical Associate Professor, Medicine - General Medical Disciplines
Current Research and Scholarly Interests Medical education research; Intergenerational teaching/learning; Analysis of effects of duty hour regulations on housestaff training and ways to improve the system
Edwin Alderman, MD
Professor of Medicine (Cardiovascular Medicine), Emeritus
Current Research and Scholarly Interests Clinical coronary artery disease: Outcome of coronary revascularization procedures compared to medical treatment. Comparison of coronary surgery with percutaneous coronary angioplasty (PTCA) for treatment of multi-vessel disease. Angiographic assessment of coronary disease severity and angiographic predictors of disease progression and of clinical events.
Ash A. Alizadeh, MD/PhD
Assistant Professor of Medicine (Oncology)
Current Research and Scholarly Interests My research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.
Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials.
Instructor, Medicine - Oncology
Current Research and Scholarly Interests I am interested in identifying targeted therapies for triple-negative breast cancers and developing a novel strategy of biomarker-based chemoprevention for hereditary cancers that arise due to mutations in the Breast Cancer Susceptibility Gene 1 (BRCA1).